Your browser doesn't support javascript.
loading
Diet supporting therapy for inflammatory bowel diseases.
Kikut, Justyna; Konecka, Nina; Zietek, Maciej; Kulpa, Danuta; Szczuko, Malgorzata.
Afiliação
  • Kikut J; Department of Human Nutrition and Metabolomics, Pomeranian Medical University, Szczecin, Poland.
  • Konecka N; Department of Applied Neurocognitivistic, Pomeranian Medical University, Szczecin, Poland.
  • Zietek M; Department of Perinatology, Obstetrics and Gynecology, Pomeranian Medical University, Szczecin, Poland.
  • Kulpa D; Department of Genetics, Plant Breeding and Biotechnology, West Pomeranian University of Technology, Szczecin, Poland.
  • Szczuko M; Department of Human Nutrition and Metabolomics, Pomeranian Medical University, Szczecin, Poland. malgorzata.szczuko@pum.edu.pl.
Eur J Nutr ; 60(5): 2275-2291, 2021 Aug.
Article em En | MEDLINE | ID: mdl-33788019
ABSTRACT

PURPOSE:

Non-specific inflammatory bowel diseases (IBD) include Crohn's disease and ulcerative colitis. More and more often attention is paid to the possibility of dietary support for inflammatory bowel diseases.

METHODS:

The following review article considers the role of dietary components in the treatment of IBD as pteridines, probiotics, bovine immunoglobulin, vitamin D, omega-3, flavonoids, polyphenols, curcumin and phosphatidylcholine. The article also discusses plant raw materials of arjuna, soy protein and nettles, trying to summarize their effect on quenching the inflammatory process within the intestines. This review focuses on the possibilities of dietary components and supplementation use to improve the pharmacotherapy response as well as the general clinical patients' condition.

RESULTS:

The mechanism of action of supportive therapy is based on reduction in oxidative stress, maintaining the adequate balance between Th1 and Th2 lymphocytes by affecting cytokines, increasing riboflavin supply for macrophages, increasing expression of vitamin D receptor, regulation by decreasing the expression of NF-κB in liver cells and ability to inhibit the COX2 entrance and inactivate prostaglandins that are involved in the inflammatory process and 12-lipoxygenase pathway inhibition.

CONCLUSION:

Considering clinical researches, it seems that the use of the above-mentioned ingredients in the diet of patients suffering IBD may positively influence the treatment process and maintenance of remission.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doenças Inflamatórias Intestinais / Colite Ulcerativa / Doença de Crohn / Probióticos Limite: Animals / Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doenças Inflamatórias Intestinais / Colite Ulcerativa / Doença de Crohn / Probióticos Limite: Animals / Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article